Replimune Group (REPL) Earnings Per Share (EPS)

Price: $7.89
Market Cap: $607.65M
Avg Volume: 740.84K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.265
52W Range: $4.92-17
Website: Replimune Group
Earnings Per Share (EPS) Summary (Annual)

According to Replimune Group's latest annual financial reports, the company has an earnings per share (EPS) of $-3.24 and a diluted EPS of $-3.24. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.

The company's EPS growth rate stands at -8.36%, and the diluted EPS growth rate is -8.36%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.

EPS

$-3.24

Diluted EPS

$-3.24

EPS Growth

-8.36%

Replimune Group Historical EPS
$0.00$0.00$-1.00$-1.00$-2.00$-2.00$-3.00$-3.00$-4.00$-4.00EPS20182018201920192020202020212021202220222023202320242024
Replimune Group Historical EPS Growth
47.83%47.83%-4.05%-4.05%-55.93%-55.93%-107.81%-107.81%EPS Growth20182018201920192020202020212021202220222023202320242024
EPS History

The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.

Year EPS Change
2024 $-3.24 -8.36%
2023 $-2.99 -32.30%
2022 $-2.26 -29.14%
2021 $-1.75 -13.64%
2020 $-1.54 -15.79%
2019 $-1.33 -107.81%
2018 $-0.64 -77.78%
2017 $-0.36 0.00%

Related Metrics

Explore detailed financial metrics and analysis for REPL.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio